Search Results - "Eichenauer, Dennis A"

COVID‐19 associated pulmonary aspergillosis by Koehler, Philipp, Cornely, Oliver A., Böttiger, Bernd W., Dusse, Fabian, Eichenauer, Dennis A., Fuchs, Frieder, Hallek, Michael, Jung, Norma, Klein, Florian, Persigehl, Thorsten, Rybniker, Jan, Kochanek, Matthias, Böll, Boris, Shimabukuro‐Vornhagen, Alexander

“…Summary Objectives Patients with acute respiratory distress syndrome (ARDS) due to viral infection are at risk for secondary complications like invasive…”
Get full text

The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG) by Hartmann, Sylvia, Eichenauer, Dennis A., Plütschow, Annette, Mottok, Anja, Bob, Roshanak, Koch, Karoline, Bernd, Heinz-Wolfram, Cogliatti, Sergio, Hummel, Michael, Feller, Alfred C., Ott, German, Möller, Peter, Rosenwald, Andreas, Stein, Harald, Hansmann, Martin-Leo, Engert, Andreas, Klapper, Wolfram

“…Nodular lymphocyte–predominant Hodgkin lymphoma (NLPHL) accounts for approximately 5% of all Hodgkin lymphoma cases. The aim of this study was to evaluate the…”
Get full text

State of the art in the treatment of Hodgkin lymphoma by Borchmann, Peter, Eichenauer, Dennis A., Engert, Andreas

“…Hodgkin lymphoma has become one of the most successfully treatable cancers; nevertheless, adverse treatment-related side effects still occur. In this Review,…”
Get full text

First use of the anti‐VWF nanobody caplacizumab to treat iTTP in pregnancy by Kühne, Lucas, Völker, Linus A., Hagmann, Henning, Hägele, Holger, Osterholt, Thomas, Eichenauer, Dennis A., Thomas, Andreas, Breuer, Johanna, Grüttner, Berthold, Gottschalk, Ingo, Kann, Martin, Benzing, Thomas, Thevis, Mario, Müller, Annette M., Brinkkoetter, Paul T.

Get full text

RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients by Eberhardt, Kirsten Alexandra, Meyer-Schwickerath, Charlotte, Heger, Eva, Knops, Elena, Lehmann, Clara, Rybniker, Jan, Schommers, Philipp, Eichenauer, Dennis A, Kurth, Florian, Ramharter, Michael, Kaiser, Rolf, Holtick, Udo, Klein, Florian, Jung, Norma, Di Cristanziano, Veronica

“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a global health emergency. To improve the understanding of the systemic component of…”
Get full text

Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma by Thurner, Lorenz, Hartmann, Sylvia, Fadle, Natalie, Regitz, Evi, Kemele, Maria, Kim, Yoo-Jin, Bohle, Rainer Maria, Nimmesgern, Anna, von Müller, Lutz, Kempf, Volkhard A. J., Weniger, Marc A., Neumann, Frank, Schneider, Nadine, Vornanen, Martine, Sundström, Christer, de Leval, Laurence, Engert, Andreas, Eichenauer, Dennis A., Küppers, Ralf, Preuss, Klaus-Dieter, Hansmann, Martin-Leo, Pfreundschuh, Michael

“…Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma of B-cell origin with frequent expression of functional B-cell receptors (BCRs)…”
Get full text

Evolutionary clonal trajectories in nodular lymphocyte-predominant Hodgkin lymphoma with high risk of transformation by Paschold, Lisa, Willscher, Edith, Bein, Julia, Vornanen, Martine, Eichenauer, Dennis A., Simnica, Donjete, Thiele, Benjamin, Wickenhauser, Claudia, Rosenwald, Andreas, Bernd, Heinz-Wolfram, Klapper, Wolfram, Feller, Alfred C., Ott, German, Fend, Falko, Hartmann, Sylvia, Binder, Mascha

“…The B-cell architecture of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is complex since it is composed of malignant lymphocyte-predominant cells…”
Get full text

Impact of timing and precision of histopathological diagnosis on outcomes of patients with Burkitt lymphoma and high‐grade B‐cell lymphoma by Graef, Claus Moritz, Gödel, Philipp, Falderbaum, Philipp, Balke‐Want, Hyatt, Simon, Florian, Sieg, Noëlle, Naendrup, Jan‐Hendrik, Neumann, Marie Anne‐Catherine, Gillessen, Sarah, Bröckelmann, Paul J., Eichenauer, Dennis A., Borchmann, Peter, Tresckow, Bastian, Heger, Jan‐Michel

“…Background Burkitt lymphoma (BL) and diffuse large B‐cell lymphoma (DLBCL) are aggressive B‐cell non‐Hodgkin lymphomas (B‐NHL) with a generally favorable…”
Get full text

Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials by Eichenauer, Dennis A, Becker, Ingrid, Monsef, Ina, Chadwick, Nicholas, de Sanctis, Vitaliana, Federico, Massimo, Fortpied, Catherine, Gianni, Alessandro M, Henry-Amar, Michel, Hoskin, Peter, Johnson, Peter, Luminari, Stefano, Bellei, Monica, Pulsoni, Alessandro, Sydes, Matthew R, Valagussa, Pinuccia, Viviani, Simonetta, Engert, Andreas, Franklin, Jeremy

“…Treatment intensification to maximize disease control and reduced intensity approaches to minimize the risk of late sequelae have been evaluated in newly…”
Get full text

ABVD in Older Patients With Early-Stage Hodgkin Lymphoma Treated Within the German Hodgkin Study Group HD10 and HD11 Trials by BÖLL, Boris, GÖRGEN, Helen, SCHMALZ, Oliver, EICHENAUER, Dennis A, VON TRESCKOW, Bastian, ROTHE, Achim, DIEHL, Volker, ENGERT, Andreas, BORCHMANN, Peter, FUCHS, Michael, PLUETSCHOW, Annette, THEODOR EICH, Hans, BARGETZI, Mario J, WEIDMANN, Eckhart, JUNGHANSS, Christian, GREIL, Richard, SCHERPE, Alexander

“…Older patients with Hodgkin lymphoma (HL) account for approximately 20% of all HL patients. ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine)…”
Get full text

Brentuximab vedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experience by Rothe, Achim, Sasse, Stephanie, Goergen, Helen, Eichenauer, Dennis A., Lohri, Andreas, Jäger, Ulrich, Bangard, Christopher, Böll, Boris, von Bergwelt Baildon, Michael, Theurich, Sebastian, Borchmann, Peter, Engert, Andreas

“…The CD30-targeting Ab-drug conjugate brentuximab vedotin (SGN-35) was recently approved for the treatment of relapsed Hodgkin lymphoma and anaplastic…”
Get full text

Prognostic accuracy of SOFA, qSOFA and SIRS criteria in hematological cancer patients: a retrospective multicenter study by Probst, Lucie, Schalk, Enrico, Liebregts, Tobias, Zeremski, Vanja, Tzalavras, Asterios, von Bergwelt-Baildon, Michael, Hesse, Nina, Prinz, Johanna, Vehreschild, Jörg Janne, Shimabukuro-Vornhagen, Alexander, Eichenauer, Dennis A, Garcia Borrega, Jorge, Kochanek, Matthias, Böll, Boris

“…With Sepsis-3, the increase in sequential organ failure assessment (SOFA) as a clinical score for the identification of patients with sepsis and quickSOFA…”
Get full text

Relapsed Hodgkin Lymphoma in Older Patients: A Comprehensive Analysis From the German Hodgkin Study Group by BÖLL, Boris, GOERGEN, Helen, BEHRINGER, Karolin, KLIMM, Beate C, NAUMANN, Ralph, DIEHL, Volker, ENGERT, Andreas, BORCHMANN, Peter, ARNDT, Nils, MEISSNER, Julia, KRAUSE, Stefan W, SCHNELL, Roland, VON TRESCKOW, Bastian, EICHENAUER, Dennis A, SASSE, Stephanie, FUCHS, Michael

“…Progression or relapse of Hodgkin lymphoma (HL) is common among older patients. However, prognosis and effects of second-line treatment are thus far unknown…”
Get full text

How I treat nodular lymphocyte-predominant Hodgkin lymphoma by Eichenauer, Dennis A., Engert, Andreas

“…Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma entity with distinct pathologic and clinical characteristics. Unlike the malignant…”
Get full text

Advances in the treatment of Hodgkin lymphoma by Eichenauer, Dennis A., Engert, Andreas

“…In the past decades, Hodgkin lymphoma (HL) has turned from an incurable disease to one with the most favorable prognosis among adult malignancies. This is due…”
Get full text

Introducing the HemaSphere Controversies Series by Eichenauer, Dennis A., Cools, Jan, Engert, Andreas

Get full text

Lymphocyte-Depleted Classical Hodgkin's Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group by KLIMM, Beate, FRANKLIN, Jeremy, STEIN, Harald, EICHENAUER, Dennis A, HAVERKAMP, Heinz, DIEHL, Volker, FUCHS, Michael, BORCHMANN, Peter, ENGERT, Andreas

“…To investigate the clinical characteristics and treatment outcome of patients with lymphocyte-depleted classical Hodgkin's lymphoma (LDCHL) compared with other…”
Get full text

Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell/histiocyte rich large B-cell lymphoma by Hartmann, Sylvia, Eichenauer, Dennis A.

“…Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is an unusual subtype of Hodgkin lymphoma characterised by a distinct histopathological and clinical…”
Get full text

Hodgkin's Lymphoma in Adolescents Treated With Adult Protocols: A Report From the German Hodgkin Study Group by Eichenauer, Dennis A, Bredenfeld, Henning, Haverkamp, Heinz, Müller, Horst, Franklin, Jeremy, Fuchs, Michael, Borchmann, Peter, Müller-Hermelink, Hans-Konrad, Eich, Hans T, Müller, Rolf-Peter, Diehl, Volker, Engert, Andreas

“…PURPOSE The standard of care for adolescent patients with Hodgkin's lymphoma (HL) is undefined, particularly the choice between pediatric and adult protocols…”
Get full text

Controversies in the Treatment of Classical Hodgkin Lymphoma by Eichenauer, Dennis A., André, Marc, Johnson, Peter, Fossa, Alexander, Casasnovas, Olivier, Engert, Andreas

“…Hodgkin lymphoma (HL) is a B‐cell‐derived malignancy that mostly affects young adults. Pathologically, HL is divided into classical HL (cHL) and the rare…”
Get full text